No Data
US Stock MarketDetailed Quotes
NLSP NLS Pharmaceutics
Watchlist
0.4901
-0.0604-10.97% Close 12/06 16:00 ET
0.4859-0.0042-0.86%
Pre 05:21 ET
0.5430High0.4625Low330.65KVolume
0.5300Open0.5505Pre Close164.30KTurnover2.33%Turnover RatioLossP/E (TTM)15.89MMarket Cap1.880052wk HighLossP/E (Static)32.43MShares0.260052wk Low4.85P/B6.95MFloat Cap7.3500Historical High--Dividend TTM14.18MShs Float0.2600Historical Low--Div YieldTTM14.62%Amplitude0.4960Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About NLS Pharmaceutics Company
NLS Pharmaceutics AG engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders. These disorders include narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as ADHD. The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.
News
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks rose Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.3%. The iShares Biotechnology ETF (IBB) was up 0.7%. In corpora
Top Midday Gainers
Bit Brother (BETS) said it has purchased 3,300 units of Antminer S19 miners to boost its mining operations. Shares of the company surged 28%, with over 175 million shares traded intraday compared with
Altimmune ALT Phase 2 Data; NLS Pharmaceutics NLSP Options Agreement